Helicobacter species in the atherosclerotic plaques of patients with coronary artery disease

Cardiovascular Pathology

Volumn 21, Issue 4, 2012, Pages 307-311

  Izadi, Morteza ^a   Fazel, Mojgan ^b   Sharubandi, Seyed Hossein ^a   Saadat, Seyed Hassan ^a   Farahani, Maryam Moshkani ^a   Nasseri, Mohammad Hassan ^a   Dabiri, Hossein ^c   Safiaryan, Reza ^a   Esfahani, Ali Akbar ^a   Ahmadi, Ali ^a   Jafari, Nematollah Jonaidi ^a   Ranjbar, Reza ^a   Jamali Moghaddam, Saeed Reza ^a   Kazemi Saleh, Davood ^a   Kalantar Motamed, Mohammad Hassan ^a   Taheri, Saeed ^d  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b International Travel Medicine Center of Iran   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Dr Taheri Medical Research Group   (Iran)

Author keywords

Atherosclerotic plaques; Coronary artery disease; Helicobacter species

Indexed keywords

CHOLESTEROL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTERY WALL; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL BIOPSY; CARDIAC PATIENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ATHEROSCLEROSIS; COMORBIDITY; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IRAN; MALE; MIDDLE AGED; PLAQUE, ATHEROSCLEROTIC; SEROEPIDEMIOLOGIC STUDIES;

EID: 84863717536     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2011.09.011     Document Type: Article

References (41)

1. D Crossman The future of the management of ischaemic heart disease BMJ 314 1997 356 359
2. PM Ridker, CH Hennekens, JE Buring, and N Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
3. G Wick, H Perschinka, and Q Xu Autoimmunity and atherosclerosis Am Heart J 138 1999 444 449
4. GK Hansson Immune and inflammatory mechanisms in the development of atherosclerosis Br Heart J 69 suppl 1 1993 S38 S41
5. OJ De Boer, AC van der Wal, and AE Becker Atherosclerosis, inflammation and infection J Pathol 190 2000 237 243
6. PM Rothwell, R Villagra, and R Gibson Evidence of a chronic systemic cause of instability of atherosclerotic plaques Lancet 355 2000 19 24
7. J George, D Harats, and Y Shoenfeld Autoimmunity in atherosclerosis: the role of autoantigens Clin Rev Allergy Immunol 18 2000 73 86
8. J George, A Afek, and B Gilburd Autoimmunity in atherosclerosis: lessons from experimental models Lupus 9 2000 223 227
9. W Osler Diseases of the arteries W Osler, T McCrae, Modern medicine: its theory and practice in original contributions by americans and foreign authors Vol. 4 1908 Lea & Febiger Philadelphia, PA 426 447
10. RS Sohal, GE Burch, and KC Chu Ultrastructural changes in cardiac capillaries of coxsackie virus B4 infected mice Lab Invest 19 1968 399 405
11. CC Kuo, A Shor, and LA Campbell Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries J Infect Dis 167 1993 841 849
12. J Beck, R Garcia, and G Heiss Periodontal disease and cardiovascular disease J Periodontol 67 Suppl. 10 1996 S1123 S1137
13. O Luis-Delgado, JJ Echevarria-Garcia, L Berini-Aytes, and C Gay-Escoda Periodontitis as a risk factor in patients with ischaemic heart disease Med Oral 9 2004 125 137
14. AC Wotherspoon, C Ortiz-Hidalgo, MR Falzon, and PG Isaacson Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma Lancet 338 1991 1175 1176
15. J Danesh, and R Peto Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies BMJ 316 1998 1130 1132
16. JG Kusters, and EJ Kuipers Helicobacter and atherosclerosis Am Heart J 138 5 pt 2 1999 S523 S527
17. J Glynn Helicobacter pylori and the heart Lancet 344 1994 146
18. M Mendall, P Goggin, and J Levy Relation of Helicobacter pylori infection and coronary heart disease Br Heart J 71 1994 437 439
19. J Danesh, R Collins, and R Peto Chronic infections and coronary heart disease: is there a link? Lancet 350 1997 430 436
20. J Danesh, Y Wong, and M Ward Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease Heart 81 1999 245 247
21. A Al-Ghamdi, AA Jiman-Fatani, and H El-Banna Role of Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus in coronary artery disease Pak J Pharm Sci 24 2 2011 95 101
22. OJ de Boer, AC van der Wal, and AE Becker Atherosclerosis, inflammation, and infection J Pathol 190 3 2000 237 243
23. F Ghasemi-Kebria, M Asmar, AH Angizeh, N Behnam-Pour, M Bazouri, E Tazike, and EA Ghaemi Seroepidemiology and determination of age trend of Helicobacter pylori contamination in Golestan province in 2008 Govaresh 14 3 2009 143 147
24. AH Alizadeh, S Ansari, M Ranjbar, HM Shalmani, I Habibi, M Firouzi, and MR Zali Seroprevalence of Helicobacter pylori in Nahavand: a population-based study East Mediterr Health J 15 1 2009 129 135
25. E Iriz, MY Cirak, ED Engin, MH Zor, D Erer, ME Ozdogan, S Turet, and A Yener Detection of Helicobacter pylori DNA in aortic and left internal mammary artery biopsies Tex Heart Inst J 35 2 2008 130 135
26. A Kilic, O Onguru, H Tugcu, S Kilic, C Guney, and Y Bilge Detection of cytomegalovirus and Helicobacter pylori DNA in arterial walls with grade III atherosclerosis by PCR Pol J Microbiol 55 4 2006 333 337
27. E Reszka, B Jegier, W Wasowicz, M Lelonek, M Banach, and Jaszewski R Detection of infectious agents by polymerase chain reaction in human aortic wall Cardiovasc Pathol 17 5 2008 297 302
28. EZ Jia, FJ Zhao, B Hao, TB Zhu, LS Wang, B Chen, KJ Cao, J Huang, WZ Ma, ZJ Yang, and G Zhang Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis Lipids Health Dis 8 2009 59
29. M Szklo, J Ding, MY Tsai, M Cushman, JF Polak, J Lima, RG Barr, and AR Sharrett Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis J Cardiovasc Med (Hagerstown) 10 10 2009 747 751
30. T Gunji, N Matsuhashi, H Sato, K Fujibayashi, M Okumura, N Sasabe, and A Urabe Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population Helicobacter 14 5 2009 144 150
31. PL Lutsey, JS Pankow, AG Bertoni, M Szklo, and AR Folsom Serological evidence of infections and type 2 diabetes: the MultiEthnic Study of Atherosclerosis Diabet Med 26 2 2009 149 152
32. M Kucukazman, B Yavuz, M Sacikara, Z Asilturk, N Ata, DT Ertugrul, AA Yalcin, EC Yenigun, G Kizilca, H Okten, KO Akin, and Y Nazligul The relationship between updated Sydney System score and LDL cholesterol levels in patients infected with Helicobacter pylori Dig Dis Sci 54 3 2009 604 607
33. B Longo-Mbenza, J Nkondi Nsenga, and D Vangu Ngoma Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics Int J Cardiol 121 3 2007 229 238
34. DJ McGee, AE George, EA Trainor, KE Horton, E Hildebrandt, and TL Testerman Cholesterol enhances Helicobacter pylori resistance to antibiotics and LL-37 Antimicrob Agents Chemother 55 6 2011 2897 2904
35. F Franceschi, AR Sepulveda, and A Gasbarrini Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis Circulation 106 2002 430 434
36. M Gunn, JC Stephens, JR Thompson, BJ Rathbone, and NJ Samani Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction Heart 84 2000 267 271
37. HC Jha, J Prasad, and A Mittal High immunoglobulin A seropositivity for combined Chlamydia pneumoniae, Helicobacter pylori infection, and high-sensitivity C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker Heart Vessels 23 6 2008 390 396
38. Y Nazligul, M Aslan, M Horoz, Y Celik, AC Dulger, H Celik, and O Erel The effect on serum myeloperoxidase activity and oxidative status of eradication treatment in patients Helicobacter pylori infected Clin Biochem 2011
39. S Aydemir, H Eren, IO Tekin, FA Harmandar, N Demircan, and M Cabuk Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels Mediators Inflamm 2010 2010 685903 [Epub 2010 Dec 13]
40. L Kebapcilar, I Sari, AH Renkal, A Alacacioglu, A Yuksel, E Ilhan, B Alkan, D Yuksel, DL Kozaci, and N Gunay The influence of Helicobacter pylori eradication on leptin, soluble CD40 ligand, oxidative stress and body composition in patients with peptic ulcer disease Intern Med 48 24 2009 2055 2059
41. GS Tamer, I Tengiz, E Ercan, C Duman, E Alioglu, and UO Turk Helicobacter pylori seropositivity in patients with acute coronary syndromes Dig Dis Sci 54 6 2009 1253 1256